Michigan: Medical Marijuana Flower Recalled in Bay City, Detroit
Michimich.com/10043356

Media Contact: LARA Communications 517-335-LARA (5272)
Email: mediainfo@michigan.gov

January 13, 2020 – The Marijuana Regulatory Agency (MRA) issued a health and safety advisory bulletin on Friday, January 10, 2020 due to the recall of medical marijuana product which failed safety compliance testing.

All affected medical marijuana is required to have a label affixed to the container that indicates the METRC number assigned to the marijuana product. Patients and caregivers should look for the production batch number associated with the product name or the individual package number which can be found under the name of the provisioning center at which the product was sold.

More on Michimich.com

• Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB)
• Put Your Herd on Your Phone: Kiko Nation Makes Livestock Management Simple
• Future Intelligence Think Tank Surpasses 1,000 Members Exploring Human and Artificial Intelligence
• Gary Bernstein Expands Media Leadership Role With Senior Strategic Advisor Appointment To Blacksun Private Equity
• Headline: House of Nova Paints Every Face in Gold at New York Fashion Week

This recall affects the following products sold at three provisioning centers in the state of Michigan between 10/14/2019 and 1/6/2020:

Production batch: 1A4050100002330000000009
Product name: Orange Burst – Buds
Failed testing: Chemical Residue (Paclobutrazol)

Pharmaco, Inc. (License # PC-000249)
3650 Patterson RD
Bay City MI 48706
Individual Package # 1A4050100002330000000415

Pharmaco, Inc. (License # PC-000261)
3557 Wilder RD
Bay City MI 48706
Individual Package # 1A4050100002330000000416

Pharmaco, Inc. (License # PC-000205)
20561 Dwyer ST
Detroit MI 48234
Individual Package # 1A405010000233000000041

Patients or caregivers who have these affected medical marijuana products in their possession should return them to the provisioning center where they were purchased for proper disposal. Provisioning centers who carried the products must notify patients or caregivers who purchased these medical marijuana products of the recall.

---

Show All News | Disclaimer | Report Violation